9:00 - 12:10
- 非上市公司路演专场
- Non-Listed Company Roadshow
主持人
- 徐佳熹 , 兴业证券董事总经理,自营分公司副总经理
- XU Jiaxi , Managing Director, China Industrial Securities
9:00 - 9:30 - 主题报告1
- Keynote Speech 1
- “数据、情报、战略”:如何用大数据解锁新药差异化立项和平衡研发风险
- "Data, Intelligence, Strategy": How to Unlock New Drug Differentiation Project Initiation and Balance R&D Risks with Big Data
- 龚元香 珠海横琴濠麦科技有限公司联合创始人&总经理
- Lena GONG , Co Founder and General Manager of Zhuhai Hengqin Haomai Technology Co., Ltd.
9:30 - 9:50 - 项目1
- Project 1
- SynNeogen®平台-慢性乙肝和前列腺癌治疗性疫苗的临床开发全新策略
- SynNeogen® Platform-A noval Strategy for the Development of Therapeutic Vaccines for Chronic HBV Infection and Prostate Cancer
- 史跃年 凯米生物医药(成都)有限公司创始人、董事长、首席执行官
- SHI Yuenian , Founder, Chairman and CEO, Chimigen Biomedical (Chengdu) Co., Ltd.
9:50 - 10:10 - 项目2
- Project 2
- 杜氏肌营养不良碱基编辑药物研究开发
- Research and Development of DMD Base Editing Drug
- 何春艳 苏州新芽基因生物技术有限公司首席执行官
- Chelsie HE , CEO, Suzhou GenAssist Co., Ltd.
10:10 - 10:30 - 项目3
- Project 3
- 立足原始创新与临床差异化实践的新药研发策略
- Innovative Drug Development Strategy Based on Original Innovation and Clinical Differentiation Practice
- 周星露 杭州和正医药有限公司首席执行官
- ZHOU Xinglu , CEO, HealZen Therapeutics Co., Ltd.
10:30 - 10:50 - 项目4
- Project 4
- 抗病毒和肝脏类疾病创新药开发
- Research and Development of Innovative Drugs for Antiviral and Liver Diseases
- 张玉华 福建广生中霖生物科技有限公司总经理
- George ZHANG , CEO, Fujian Akeylink Bio
10:50 - 11:10 - 项目5
- Project 5
- 基于脆弱拟杆菌的创新活体药开发
- Innovative in Vivo Drug Development Based on Bacteroides Fragilis
- 王晔 广州知易生物科技有限公司首席执行官
- WANG Ye , CEO, Guangzhou Zhiyi Biotechnology Co., Ltd.
11:10 - 11:30 - 项目6
- Project 6
- 用表型筛选系统开发治疗CNS的FIC药物
- Discovery and Development of FIC Drug in CNS by Phenotypic Screening
- 马伟伟 北京卓凯生物技术有限公司总经理
- MA Weiwei , CEO, Beijing Joekai Biotechnology Llc
11:30 - 11:50 - 项目7
- Project 7
- 聚焦肿瘤与肾病未满足临床需求,做好药为生命更美好
- Focused on the Unmet Needs in Oncology and Nephrology, Making Better Medicine for Better Life
- 黑永疆 无锡智康弘义生物科技有限公司联席首席执行官
- HEI Yongjiang , Co-CEO, Biocity Biopharma
11:50 - 12:10 - 项目8
- Project 8
- 澳宗生物于CNS领域新药研发进展
- Auzone Bio's New Drug Discovery and Development Progress in the CNS Field
- 侯尚伟 苏州澳宗生物科技有限公司首席运营官
- HOU Shangwei , Chief Operating Officer, Suzhou Auzone Biotechnology Co., Ltd.